Cytek Biosciences Inc
NASDAQ:CTKB
Cytek Biosciences Inc
Revenue
Cytek Biosciences Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cytek Biosciences Inc
NASDAQ:CTKB
|
Revenue
$193m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Revenue
$2.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Cytek Biosciences Inc
Revenue Breakdown
Breakdown by Geography
Cytek Biosciences Inc
Total Revenue:
193m
USD
|
United States:
102.1m
USD
|
EMEA:
53.2m
USD
|
Asia Pacific:
31.6m
USD
|
Other:
6.2m
USD
|
Breakdown by Segments
Cytek Biosciences Inc
Total Revenue:
193m
USD
|
Product:
156.7m
USD
|
Service:
36.3m
USD
|
See Also
What is Cytek Biosciences Inc's Revenue?
Revenue
193m
USD
Based on the financial report for Dec 31, 2023, Cytek Biosciences Inc's Revenue amounts to 193m USD.
What is Cytek Biosciences Inc's Revenue growth rate?
Revenue CAGR 3Y
28%
Over the last year, the Revenue growth was 18%. The average annual Revenue growth rates for Cytek Biosciences Inc have been 28% over the past three years .